Sungman Cha

Structure-activity relationship of ligands of the pyrimidine nucleoside phosphorylases

Eighty-seven pyrimidine base and nucleoside analogs were evaluated as inhibitors of uridine phosphorylase (UrdPase) and thymidine phosphorylase (dThdPase). These findings, together with an extensive literature review, have allowed construction of structure-activity relationships for the binding of ligands to UrdPase and dThdPase and provide a basis for the rational design of new inhibitors of these enzymes. Additionally, 2,6-pyridinediol and 6-benzyl-2-thiouracil have been identified as being potent inhibitors of UrdPase and dThdPase respectively.

Pyrimidine acyclonucleosides, inhibitors of uridine phosphorylase

Abstract A new class of nucleoside analogs, the pyridimine acyclonucleosides, are competitive inhibitors of uridine phosphorylase but have no effect on thymicline phosphorylase, uridine kinase or thymidine kinase. The most potent of the series is acyclothymidine [5-methyl-1-(2′-hydroxyethoxymethyl)uracil] with a Ki value of 3 μM. Ki values of less than 30 μM were estimated for other analogs substituted at the 5-position of the pyrimicline ring. Extracts of xenografts of six human tumors were assayed for tissue levels of uricline phosphorylase and thymicline phosphorylase and for inhibition of 5-fluoro-2′-deoxyuridine (FUdR) phosphorolytic activity by acyclouridine [1-(2′-hydroxyethoxymethyl) uracil]. FUdR cleavage was inhibited most in those tissues in which the ratio of thymidine phosphorylase to uricline phosphorylase was low. Potential usage of these uricline phosphorylase inhibitors with the chemotherapeutic agent FUdR is discussed.

Structure-activity relationship of ligands of dihydrouracil dehydrogenase from mouse liver☆

One hundred and five nucleobase analogues were screened as inhibitors of dihydrouracil dehydrogenase (DHUDase, EC 1.3.1.2) from mouse liver. 5-Benzyloxybenzyluracil, 1-deazauracil (2,6-pyridinediol), 3-deazauracil (2,4-pyridinediol), 5-benzyluracil, 5-nitrobarbituric acid and 5,6-dioxyuracil (alloxan) were identified as potent inhibitors of this activity, with apparent Ki values of 0.2, 0.5, 2.1, 3.4, 3.8 and 6.6 microM respectively. Both 5-benzyloxybenzyluracil and 1-deazauracil were also potent inhibitors of DHUDase from human livers. These findings along with an extensive review of literature allowed the formulation of a structure-activity relationship. The binding to DHUDase required intact C2 and C4 oxo groups. Replacement of N1 or N3 by an endocyclic carbon enhanced binding. In contrast, replacement of C5 or C6 by an endocyclic nitrogen abolished binding. Addition of a charged group to C5 and/or C6, and of a hydrophobic group to C5 but not C6 improved the binding.

A new enzymatic method for the determination of inorganic phosphate and its application to the nucleoside diphosphatase assay

Abstract A new enzymatic method has been developed for the determination of inorganic phosphate, in which purine nucleoside phosphorylase and xanthine oxidase are used as indicator enzymes. This method has been applied to the assay of nucleoside diphosphatase. Incidental to this work, the apparent Michaelis constant of phosphate for calf spleen purine nucleoside phosphorylase was determined to be 0.25 m m , and the extinction coefficient of uric acid at 293 nm and pH 7.4 was found to be 13.0 × 103 m −1 cm−1.

Synthesis of 5-Benzyl and 5-Benzyloxybenzyl 2,2′-Anhydrouridines and Related Nucleoside Analogs as Inhibitors of Uridine Phosphorylase

Abstract Furanosyl analogs of BAU (5-benzylacyclouridine) and BBAU (5-benzyloxybenzylacyclouridine), two potent inhibitors of uridine phosphorylase, were synthesized and evaluated as potential cancer chemotherapeutic agents. The analogs included ribosides, 2,2′-anhydro nucleosides, arabinosides and deoxyribosides. The anhydrouridine intermediates were potent inhibitors of uridine phosphorylase and good potentiators of FdUrd activity in human tumor cells in culture.

Microdetermination of guanine ribonucleotides by an enzymic amplification technique

Abstract A method has been described by which GMP, GDP, and GTP in tissue extracts in an amount of 10−10 mole or less can be determined without any separation procedure. The sum of concentrations of GDP and GTP is measured by the system involving guanine nucleotide specific succinate thiokinase from pig heart and pyruvate kinase coupled in a cyclic manner. In this system the rate of pyruvate formation from phosphoenolpyruvate is proportional to the sum of GDP and GTP concentrations and pyruvate is allowed to accumulate to a concentration up to several 1000-fold higher than the sum of GDP and GTP concentrations. Then the pyruvate concentration is determined by lactate dehydrogenase. The sum of GMP, GDP, and GTP is determined by repeating the same procedure after GMP is converted to GDP by pretreating the sample with guanylate kinase in the presence of ATP, phosphocreatine, and creatine kinase. The concentration of GTP is measured by repeating the same procedure after GDP is removed from the mixture by pretreating with nucleoside diphosphatase. Finally, the concentrations of the individual nucleotides are calculated from these three determinations. Incidental to this work, methods were described for the purification of commerical ATP and CoA preparations which have been found to contain significant amounts of GDP and GTP.

Effects of N,N-dimethylformamide and sodium butyrate on enzymes of pyrimidine metabolism in cultured human tumor cells

Effects of a 7-day treatment with the maturational agents DMF and sodium butyrate on enzymes of pyrimidine metabolism, growth rate and cell maturation were assessed in 5 human tumor cell lines, ARH-77 (myeloma), K-562 (chronic myeloid leukemia), KG-1 (myeloid leukemia), HL-60 (promyelocytic leukemia) and RWLy-1 (non-Hodgkins lymphoma). DMF lengthened the doubling times of all five cell lines while sodium butyrate lengthened only those of K-562, HL-60 and RWLy-1. Full maturation was induced only in HL-60 by either agent and in K-562 by butyrate. Exposure resulted in a decreased activity of the anabolic enzyme orotate phosphoribosyltransferase (EC 2.4.2.10) and increased activities of the catabolic enzymes thymidine phosphorylase (EC 2.4.2.4) and dihydrouracil dehydrogenase (EC 1.3.1.2). Changes in the amphibolic enzyme, uridine phosphorylase (EC 2.4.2.3) did not follow any apparent pattern. This study indicates that the pattern of pyrimidine metabolism differs between the differentiated and slowly growing, and undifferentiated rapidly growing counterpart of several human tumors, suggesting that enzymes of pyrimidine metabolism can be used as markers for cellular growth and/or maturity.

A simple radioisotopic assay for nucleoside kinases employing alumina for separation of nucleosides and nucleotides

Abstract A rapid, simple, and sensitive radiochemical assay for the measurement of purine or pyrimidine nucleoside kinases (EC 2.7.1.-) is described. The substrate (thymidine, deoxyuridine, deoxycytidine, deoxyguanosine, deoxyadenosine, uridine, cytidine, and adenosine) is separated from the product (the respective 5′-nucleotide) on neutral alumina columns which retain the nucleotides but not the nucleosides. The nucleotides are recovered by elution with 0.4 m sodium phosphate buffer, pH 7.6.